Asieris Pharmaceuticals
亚虹医药
Asieris Pharmaceuticals
Biotech/Healthcare
Asieris Pharmaceuticals, founded in March 2010, is a global innovative drug company focused on urogenital system tumors and other major diseases. Guided by its mission of "improving human health and giving life more dignity," Asieris aims to become an internationally leading pharmaceutical company…
Latest round: Series C (2020)
Source: ChinaBulls — chinabulls.com
Last updated 2020-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.